DENYES NANCY (General Counsel) sold 3.3% of their position (1.12K shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $1.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001193125-26-037996
Officer· General Counsel
Since Feb 2019
-1.12K
Net shares
Net seller
$1.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.69K acquired · 3.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.69K
Price / share
—
Trade value
—
% of position
8.5%
2/3/2026
31.55K→34.24K
Common Stock
Direct
Shares
−1.12K
Price / share
$0.98
Trade value
$1.09K
% of position
3.3%
2/4/2026
34.24K→33.12K
Total
Net shares
+1.57K
Net value
-$1.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +2.69K | — | — | 8.5% | 31.55K | 34.24K |
| Common Stock Direct | 2/4/2026 | S · Sale | −1.12K | $0.98 | $1.09K | 3.3% | 34.24K | 33.12K |
| Total | +1.57K | -$1.09K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
2.69K shares
Shares
−2.69K
Strike price
Held after
0.00
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.69K shares | 2/3/2026 | M · Option Exercise | −2.69K | — | 0.00 |